SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-034876
Filing Date
2022-12-08
Accepted
2022-12-08 14:26:39
Documents
44
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 959692
2 ex31.htm EX-31 18414
3 ex32.htm EX-32 6821
  Complete submission text file 0001493152-22-034876.txt   4177067

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clcs-20220930.xsd EX-101.SCH 29567
5 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT clcs-20220930_cal.xml EX-101.CAL 39874
6 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT clcs-20220930_def.xml EX-101.DEF 159556
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clcs-20220930_lab.xml EX-101.LAB 277012
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clcs-20220930_pre.xml EX-101.PRE 217235
38 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 596787
Mailing Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019
Business Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019 646-612-7554
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

IRS No.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55413 | Film No.: 221452183
SIC: 2834 Pharmaceutical Preparations